
ObjectiveDespite a 90% reperfusion rate, only 50% of patients with anterior circulation large vessel occlusion‐related acute ischemic stroke (LVO‐AIS) have a functional recovery at 3 months. Parenchymal hematoma (PH) is a predictor of poor outcome after endovascular treatment (EVT). We aim to investigate the relationship between the delay from onset to reperfusion, the occurrence of PH, and functional outcome.MethodsThe Endovascular Treatment in Ischemic Stroke (ETIS) registry is an ongoing prospective observational study. Data were analyzed from the subgroup of patients who underwent a successful EVT defined by a modified Thrombolysis in Cerebral Infarction (mTICI) score 2b‐3. We assessed the factors associated with PH, (ie, PH1 or PH2 grade according to the European Collaborative Acute Stroke Study 2 (ECASS) classification of hemorrhagic transformation), then evaluated the relationships between PH, delay from onset to reperfusion, and functional recovery defined by a modified Rankin Scale (mRS) of 0–2.ResultsWe analyzed 2,919 patients with an LVO‐related AIS who underwent a successful EVT. Overall, 13.3% of the participant experienced a PH. The rate of PH increased by 2.5% (95% CI 1.5%–3.6%, p < 0.001) for every additional hour of onset to reperfusion delay and was, by comparison with the other study patients, consistently associated with a lower rate of functional recovery 19.7% (95% CI 11.6%–27.7%, p < 0.001) irrespective of time from onset to reperfusion.InterpretationOur results demonstrate that PH rate is associated with the delay from onset to reperfusion and participates in the relationship between time to reperfusion and outcome. Time is Bleeding. ANN NEUROL 2022;92:882–887
MESH: Brain Ischemia* / therapy, Brain Ischemia/therapy, 610, MESH: Endovascular Procedures* / methods, Stroke/therapy, Sciences de la santé humaine, MESH: Brain Ischemia* / complications, Brain Ischemia, MESH: Reperfusion / methods, Reperfusion/methods, Brain Ischemia/complications, Neurologie, 616, Humans, [SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], Human health sciences, MESH: Ischemic Stroke*, MESH: Treatment Outcome, Ischemic Stroke, Retrospective Studies, MESH: Humans, MESH: Stroke* / therapy, Endovascular Procedures, MESH: Retrospective Studies, Endovascular Procedures/methods, Stroke, Treatment Outcome, Neurology, Reperfusion, [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], Neurology (clinical)
MESH: Brain Ischemia* / therapy, Brain Ischemia/therapy, 610, MESH: Endovascular Procedures* / methods, Stroke/therapy, Sciences de la santé humaine, MESH: Brain Ischemia* / complications, Brain Ischemia, MESH: Reperfusion / methods, Reperfusion/methods, Brain Ischemia/complications, Neurologie, 616, Humans, [SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], Human health sciences, MESH: Ischemic Stroke*, MESH: Treatment Outcome, Ischemic Stroke, Retrospective Studies, MESH: Humans, MESH: Stroke* / therapy, Endovascular Procedures, MESH: Retrospective Studies, Endovascular Procedures/methods, Stroke, Treatment Outcome, Neurology, Reperfusion, [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], Neurology (clinical)
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 16 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
